MedPath

TcMS to Treat Ventricular Tachycardia

Not Applicable
Withdrawn
Conditions
Ventricular Tachycardia
Interventions
Device: TcMS
Registration Number
NCT05016921
Lead Sponsor
University of Pennsylvania
Brief Summary

Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age >18years
  • Documented ventricular tachycardia within the preceding 72 hours
Read More
Exclusion Criteria
  • Pregnancy
  • Implanted ventricular assist device
  • Metal implanted in heard or neck (except the mouth)
  • Implanted medication pumps
  • Cochlear implant
  • Implanted brain stimulator
  • Ocular implant
  • History of malignancy in the region of stimulation (neck)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transcutaneous magnetic stimulationTcMSTranscutaneous magnetic stimulation targeting the stellate ganglion
Primary Outcome Measures
NameTimeMethod
Ventricular Tachycardia0-72 hours after enrollment

Burden (number of episodes) of ventricular tachycardia

Secondary Outcome Measures
NameTimeMethod
Non sustained ventricular tachycardia0-72 hours after enrollment

Burden (number of episodes) of ventricular tachycardia

DiscomfortAssessed immediately following stimulation

Discomfort experienced during stimulation (on scale of 0-10) reported by patient

Trial Locations

Locations (1)

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath